Effectiveness of yohimbine in treating narcolepsy

Area of Science:

• Neurology
• Sleep Medicine
• Pharmacology

Background:

• Narcolepsy is a chronic neurological disorder characterized by excessive daytime sleepiness.
• Alpha-2 adrenergic receptor abnormalities are hypothesized to play a role in narcolepsy pathophysiology.

Purpose of the Study:

• To investigate the efficacy of yohimbine as a treatment for narcolepsy.
• To determine the effective dosage and duration of response for yohimbine in narcolepsy patients.

Main Methods:

• A study involving eight patients (four men, four women) aged 21-64 with narcolepsy confirmed by polysomnography and multiple sleep latency testing.
• Patients received yohimbine, with dosages adjusted to maintain subjective wakefulness for 8 hours.

Main Results:

• All participants achieved a stimulant response to yohimbine, with effective doses ranging from 2.7 to 16.2 mg/day (average ~8 mg/day).
• One patient developed immediate tolerance, while others maintained response for weeks; one patient experienced sustained control for 17 months.
• Reported side effects were mild and transient, including insomnia, diarrhea, dyspepsia, flushing, and tremor.

Conclusions:

• Yohimbine demonstrates potential as an effective treatment for managing sleepiness in narcolepsy.
• The findings support the hypothesis of alpha-2 adrenergic receptor involvement in narcolepsy, suggesting yohimbine's mechanism of action.
• Further research is warranted to explore yohimbine's long-term efficacy and safety profile in narcolepsy management.